Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Queensland Health
Harvard Business School
QuintilesIMS
Mallinckrodt
Dow
Novartis
Fuji
Medtronic
Fish and Richardson

Generated: October 21, 2017

DrugPatentWatch Database Preview

Fospropofol disodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for fospropofol disodium and what is the scope of fospropofol disodium freedom to operate?

Fospropofol disodium
is the generic ingredient in one branded drug marketed by Eisai Inc and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Fospropofol disodium has thirty-four patent family members in twenty-five countries.

Summary for Generic Name: fospropofol disodium

US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Clinical Trials: see list166
Drug Prices:see low prices
DailyMed Link:fospropofol disodium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eisai Inc
LUSEDRA
fospropofol disodium
SOLUTION;INTRAVENOUS022244-001Dec 12, 2008DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Eisai Inc
LUSEDRA
fospropofol disodium
SOLUTION;INTRAVENOUS022244-001Dec 12, 2008DISCNNoNo► Subscribe► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: fospropofol disodium

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,451,776 Water soluble prodrugs of hindered alcohols► Subscribe
7,244,718Water soluble prodrugs of hindered alcohols► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: fospropofol disodium

Country Document Number Estimated Expiration
Australia769755► Subscribe
Australia5339499► Subscribe
Japan2002522443► Subscribe
European Patent Office1683803► Subscribe
World Intellectual Property Organization (WIPO)0008033► Subscribe
Turkey200100772► Subscribe
Hong Kong1047939► Subscribe
MexicoPA01001431► Subscribe
Norway330357► Subscribe
Poland198141► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
US Army
Boehringer Ingelheim
Federal Trade Commission
Merck
Covington
QuintilesIMS
Citi
Chinese Patent Office
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot